Bruce & Co
Latest statistics and disclosures from Bruce & Co's latest quarterly 13F-HR filing:
- Top 5 stock holdings are NextEra Energy, ABBV, ALL, AER, Merck & Co, and represent 36.76% of Bruce & Co's stock portfolio.
- Added to shares of these 4 stocks: BBNX (+$5.5M), APOG, SUPN, FATE.
- Started 2 new stock positions in APOG, BBNX.
- Reduced shares in these 5 stocks: VICR, DUK, NextEra Energy, XEL, KOD.
- Bruce & Co was a net buyer of stock by $372k.
- Bruce & Co has $350M in assets under management (AUM), dropping by 8.41%.
- Central Index Key (CIK): 0001358331
Tip: Access up to 7 years of quarterly data
Positions held by Bruce & Co consolidated in one spreadsheet with up to 7 years of data
Download as csvPortfolio Holdings for Bruce & Co
Bruce & Co holds 41 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Nextera Energy Common | 8.0 | $28M | -3% | 300k | 92.88 |
|
| Abbvie Common (ABBV) | 7.6 | $27M | 123k | 217.49 |
|
|
| Allstate Common (ALL) | 7.3 | $26M | 126k | 204.34 |
|
|
| AerCap Holdings Common (AER) | 7.2 | $25M | 184k | 137.18 |
|
|
| Merck Common | 6.6 | $23M | 193k | 120.29 |
|
|
| Uhaul B Common (UHAL.B) | 5.8 | $20M | 452k | 44.67 |
|
|
| Duke Energy Common (DUK) | 5.5 | $19M | -6% | 146k | 130.94 |
|
| At & T Common (T) | 4.3 | $15M | 523k | 28.99 |
|
|
| XCEL Energy Common (XEL) | 4.2 | $15M | -5% | 185k | 79.44 |
|
| CMS Energy Common (CMS) | 3.5 | $12M | 156k | 77.58 |
|
|
| Abbott Common (ABT) | 3.3 | $12M | 114k | 102.67 |
|
|
| Insteel Common (IIIN) | 3.3 | $12M | 343k | 33.90 |
|
|
| Newmont Common (NEM) | 3.1 | $11M | 100k | 108.25 |
|
|
| Vicor Common (VICR) | 3.0 | $11M | -27% | 65k | 161.00 |
|
| Apple Common (AAPL) | 2.8 | $9.9M | 39k | 253.79 |
|
|
| Bunge Common (BG) | 2.5 | $8.9M | 70k | 127.20 |
|
|
| Avista Common (AVA) | 2.3 | $8.1M | 202k | 40.14 |
|
|
| Pfizer Common (PFE) | 2.2 | $7.6M | 272k | 28.08 |
|
|
| Archer Daniels Common (ADM) | 2.1 | $7.3M | 100k | 72.69 |
|
|
| Darling Ingredients Common (DAR) | 1.9 | $6.6M | 106k | 61.85 |
|
|
| Kodiak Sciences Common (KOD) | 1.6 | $5.5M | -12% | 145k | 38.12 |
|
| Beta Bionics Common (BBNX) | 1.6 | $5.5M | NEW | 551k | 10.02 |
|
| Chemours Common (CC) | 1.6 | $5.5M | 250k | 22.03 |
|
|
| Supernus Common (SUPN) | 1.5 | $5.2M | +21% | 100k | 51.69 |
|
| Lyondellbasell Common (LYB) | 1.4 | $4.8M | 60k | 80.56 |
|
|
| Uhaul Common (UHAL) | 1.0 | $3.5M | 74k | 47.78 |
|
|
| Rli Common (RLI) | 0.7 | $2.3M | 41k | 57.04 |
|
|
| Eli Lilly Common (LLY) | 0.5 | $1.8M | 2.0k | 919.77 |
|
|
| Apogee Common (APOG) | 0.5 | $1.7M | NEW | 50k | 33.54 |
|
| Edap Common (FOCL) | 0.5 | $1.6M | 439k | 3.72 |
|
|
| Venture Global Common (VG) | 0.5 | $1.6M | 100k | 15.76 |
|
|
| Personalis Common (PSNL) | 0.4 | $1.5M | 233k | 6.37 |
|
|
| XM Sirius Common | 0.4 | $1.3M | 56k | 23.08 |
|
|
| Fate Theraputics Common (FATE) | 0.3 | $947k | +8% | 789k | 1.20 |
|
| Ashland Common | 0.2 | $834k | 15k | 55.61 |
|
|
| Viatris Common (VTRS) | 0.2 | $787k | 58k | 13.51 |
|
|
| Bausch Health Common | 0.2 | $670k | 124k | 5.40 |
|
|
| Mannkind Common (MNKD) | 0.1 | $478k | 195k | 2.45 |
|
|
| Caribou Biosciences Common (CRBU) | 0.1 | $475k | 250k | 1.90 |
|
|
| WEC Energy Common (WEC) | 0.1 | $457k | 3.9k | 115.77 |
|
|
| 908 Devices Common (MASS) | 0.1 | $418k | 68k | 6.12 |
|
Past Filings by Bruce & Co
SEC 13F filings are viewable for Bruce & Co going back to 2010
- Bruce & Co 2026 Q1 filed May 14, 2026
- Bruce & Co 2025 Q4 filed Feb. 13, 2026
- Bruce & Co 2025 Q3 filed Nov. 13, 2025
- Bruce & Co 2025 Q2 filed Aug. 14, 2025
- Bruce & Co 2025 Q1 filed May 14, 2025
- Bruce & Co 2024 Q4 filed Feb. 11, 2025
- Bruce & Co 2024 Q3 filed Nov. 14, 2024
- Bruce & Co 2024 Q2 filed Aug. 9, 2024
- Bruce & Co 2024 Q1 filed May 13, 2024
- Bruce & Co 2023 Q4 filed Feb. 12, 2024
- Bruce & Co 2023 Q3 filed Nov. 13, 2023
- Bruce & Co 2023 Q2 filed Aug. 8, 2023
- Bruce & Co 2023 Q1 filed May 12, 2023
- Bruce & Co 2022 Q4 filed Feb. 15, 2023
- Bruce & Co 2022 Q3 filed Nov. 15, 2022
- Bruce & Co 2022 Q2 filed Aug. 9, 2022